4D Molecular Therapeutics (FDMT) Margins & Profitability 2020-2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- EBITDA Margin
- -2002.8%
- Op. Margin
- -2037.2% 99.5%
- Net Margin
- -1929.0% 99.5%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit